ConductScience.org, home

Gene · 4607

Papers3,985

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

161 to 180 of 3,985

Download this page as JSON
TitleJournalYearPMIDFound bySource
Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and United Kingdom ancestry.Precis Clin Med202540860236PubTator, text miningPubMed
Next-generation RNA sequencing of spatially mapped material from human body donors for testing the impact of fetal environments on the liver transcriptome.Sci Rep202540858696PubTator, text miningPubMed
Cardiac myosin inhibitors - a cutting-edge solution for the management of hypertrophic cardiomyopathy: a narrative review.Ann Med Surg (Lond)202540852013PubTator, text miningPubMed
A FRET assay to monitor different structural states of human β-cardiac myosin including the interacting-heads motif.Proc Natl Acad Sci U S A202540833405PubTator, text miningPubMed
Artificial Intelligence in Hypertrophic Cardiomyopathy: Advances, Challenges, and Future Directions for Personalized Risk Prediction and Management.Cureus202540809637PubTator, text miningPubMed
Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling.Front Cardiovasc Med202540791945PubTator, text miningPubMed
User testing of a previsit chatbot developed for population genomic screening and counseling.J Genet Couns202540767085PubTator, text miningPubMed
Clinical manifestations, genetic profiles, and sudden cardiac arrest in pediatric hypertrophic cardiomyopathy: Challenges of risk prediction for initial sudden cardiac arrest presentations.Heart Rhythm O2202540734749PubTator, text miningPubMed
Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure.J Am Heart Assoc202540728184PubTator, text miningPubMed
Formation of an Amyloid-like Structure During In Vitro Interaction of Titin and Myosin-Binding Protein C.Int J Mol Sci202540725155PubTator, text miningPubMed
Next-Generation Approaches in Sports Medicine: The Role of Genetics, Omics, and Digital Health in Optimizing Athlete Performance and Longevity-A Narrative Review.Life (Basel)202540724525PubTator, text miningPubMed
Abstracts of the 3rd UNICA Sport Science International Conference 2024.Sports Med Open202540719936PubTator, text miningPubMed
Clinical features, imaging characteristics, and genetic profile of hypertrophic cardiomyopathy patients in India.Indian Heart J202540675549PubTator, text miningPubMed
Spatially resolving how cMyBP-C phosphorylation and haploinsufficiency in porcine and human myofibrils affect β-cardiac myosin activity.J Gen Physiol202540622308PubTator, text miningPubMed
Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy.ESC Heart Fail202540613316PubTator, text miningPubMed
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial.Cardiovasc Res202540601822PubTator, text miningPubMed
Editorial: State-of-the-art muscle physiology research: from single molecules and cells to living organisms.Front Physiol202540600124PubTator, text miningPubMed
Cardiac phenotype characterization at magnetic resonance imaging in alpha-protein kinase 3-associated hypertrophic cardiomyopathy.J Cardiovasc Magn Reson202540581189PubTator, text miningPubMed
[Genetic analysis of six adult patients with Dilated cardiomyopathy and analysis of structural variants].Zhonghua Yi Xue Yi Chuan Xue Za Zhi202540555656PubTator, text miningPubMed
Sudden Cardiac Arrest in a Young Adult: A Diagnostic Challenge.Cureus202540546560PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4607/papers?page=9